Redx installs Natalie Berner as Non-Executive Director

pharmafile | June 2, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on the board of directors.

Natalie brings extensive experience from the healthcare sector to the board. She is a Managing Director focusing on therapeutics at Redmile.

Iain Ross, Chairman of the Board of Redx, commented: “We are delighted to welcome Natalie onto the Redx board to represent Redmile, one of the company’s key investors who have been instrumental in helping us to raise the funds to successfully execute on our business plans. The board and I look forward to working with Natalie to ensure that we continue to grow Redx into a successful biotech company focused on the treatment of cancer and fibrotic disease.”

Related Content

No items found

Latest content